Acrux Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARUXF research report →
Price Chart
About the company
Acrux Limited and its associated entities specialize in the development and commercialization of generic and topically applied pharmaceutical products. Their global operations span Australia, Europe, the United States, and various other international markets. The company provides a comprehensive range of testosterone therapies for adult males experiencing insufficient or absent testosterone levels, including oral and buccal tablets, subcutaneous pellets, transdermal patches, injectable formulations, and topical gels.
- CEO
- John Warmbrunn
- IPO
- 2010
- Employees
- 43
- HQ
- West Melbourne, VIC, AU
Get TickerSpark's AI analysis on ARUXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.41M
- P/E
- -7.14
- Fwd P/E
- 0.52
- PEG
- -0.04
- P/S
- 1.32
- P/B
- 2.86
- EV/EBITDA
- -4.08
- Div Yield
- 0.00%
- Gross Margin
- 90.57%
- Op Margin
- -46.06%
- Net Margin
- -13.01%
- ROE
- -45.29%
- ROIC
- -10.70%
Latest fiscal year · YoY change
- Revenue
- $4.64M+289.7%
- Gross Profit
- $4.20M+253.0%
- Op Income
- $-2,136,000
- Net Income
- $-603,153+89.9%
- EPS
- $-0.00+91.7%
- OCF Growth
- +118.6%
- FCF Growth
- +118.6%
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 0.97
- RSI (14)
- 69
- Avg Volume
- 1.05K
No earnings-call transcripts are available for ARUXF yet.
- Free Float
- 76.8%
- Shares Outstanding
- 401.43M
- Float Shares
- 308.37M
Our ARUXF coverage
Recent articles, reports, and earnings notes.
No research on ARUXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARUXF report →